NL7005499A - - Google Patents
Info
- Publication number
- NL7005499A NL7005499A NL7005499A NL7005499A NL7005499A NL 7005499 A NL7005499 A NL 7005499A NL 7005499 A NL7005499 A NL 7005499A NL 7005499 A NL7005499 A NL 7005499A NL 7005499 A NL7005499 A NL 7005499A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
- C07J1/004—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0048—Alkynyl derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0081—Substituted in position 17 alfa and 17 beta
- C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
- C07J1/0096—Alkynyl derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81683769A | 1969-04-16 | 1969-04-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL7005499A true NL7005499A (cs) | 1970-10-20 |
Family
ID=25221743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7005499A NL7005499A (cs) | 1969-04-16 | 1970-04-16 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US3658854A (cs) |
| CH (1) | CH536828A (cs) |
| FR (1) | FR2042331B1 (cs) |
| GB (1) | GB1296773A (cs) |
| NL (1) | NL7005499A (cs) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1250819B (de) * | 1962-11-23 | 1967-09-28 | Ciba Aktiengesellschaft, Basel (Schweiz) | Verfahren zur Herstellung von 3-Hydroxy - (bzw. -Acyloxy)-7a-alkyl-19-nor-4androstenen |
| GB1022422A (en) * | 1965-02-02 | 1966-03-16 | Merck Ag E | Oestradiol ester and preparation thereof |
-
1969
- 1969-04-16 US US816837A patent/US3658854A/en not_active Expired - Lifetime
-
1970
- 1970-04-07 GB GB1296773D patent/GB1296773A/en not_active Expired
- 1970-04-13 FR FR7013276A patent/FR2042331B1/fr not_active Expired
- 1970-04-13 CH CH559670A patent/CH536828A/de not_active IP Right Cessation
- 1970-04-16 NL NL7005499A patent/NL7005499A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CH536828A (de) | 1973-05-15 |
| FR2042331B1 (cs) | 1974-04-12 |
| DE2017578A1 (cs) | 1970-10-29 |
| FR2042331A1 (cs) | 1971-02-12 |
| US3658854A (en) | 1972-04-25 |
| DE2017578B2 (de) | 1975-07-31 |
| GB1296773A (cs) | 1972-11-15 |